2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Breast Neoplasms
21
Prostatic Neoplasms
7
Thyroid Nodule
4
Neoplasms
4
Liver Neoplasms
4
Urinary Bladder Neoplasms
3
Squamous Cell Carcinoma of Head and Neck
3
Sarcopenia
3
Rectal Neoplasms
3
Polycystic Ovary Syndrome
3
Pancreatic Neoplasms
3
Ovarian Neoplasms
3
Mouth Neoplasms
3
Liver Cirrhosis
3
Endometrial Neoplasms
3
Brain Neoplasms
3
Uterine Cervical Neoplasms
2
Tongue Neoplasms
2
Thyroid Neoplasms
2
Postoperative Complications
2
Ovarian Cysts
2
Lung Neoplasms
2
Kidney Neoplasms
2
Hypersensitivity
2
Head and Neck Neoplasms
2
Colorectal Neoplasms
2
Carcinoma, Hepatocellular
2
Uveal Melanoma
1
Urologic Neoplasms
1
Urethral Neoplasms
1
Interventions
Timolol
7
Propranolol
7
Lasers, Dye
3
Population Groups
2
Nadolol
2
Imiquimod
2
Atenolol
2
ziprasidone
1
propranolol mustard
1
Zolpidem
1
Warfarin
1
Vecuronium Bromide
1
Vancomycin
1
Ultrasonography
1
Tranexamic Acid
1
Tobramycin
1
Surgery, Computer-Assisted
1
Spironolactone
1
Sevelamer
1
Rocuronium
1
Piperacillin, Tazobactam Drug Combination
1
Pentobarbital
1
Oxycodone
1
Ophthalmic Solutions
1
Ointments
1
Nifedipine
1
Nafcillin
1
Mupirocin
1
Molindone
1
Methylprednisolone
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Hemangioma, Capillary
×
Ultrasonography
×
Clear all
NCT05484245
2025-05-16
SOMALI
Sklifosovsky Institute of Emergency Care
Phase NA
Recruiting
100 enrolled